Zhao S, Dong C, Chang C, Zhang J, Li J, Zhang X
Front Med (Lausanne). 2025; 11:1519686.
PMID: 39927273
PMC: 11802545.
DOI: 10.3389/fmed.2024.1519686.
Nguyen L, Nguyen T, Kim J, Jeong J
J Nanobiotechnology. 2024; 22(1):745.
PMID: 39616384
PMC: 11608496.
DOI: 10.1186/s12951-024-03004-3.
Zou Y, Guo Z, Ge X, Qiu Y
Microorganisms. 2024; 12(11).
PMID: 39597761
PMC: 11596894.
DOI: 10.3390/microorganisms12112373.
Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X
Genes Dis. 2024; 12(1):101215.
PMID: 39534573
PMC: 11555349.
DOI: 10.1016/j.gendis.2024.101215.
Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z
Virulence. 2024; 15(1):2421231.
PMID: 39460469
PMC: 11583590.
DOI: 10.1080/21505594.2024.2421231.
The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption.
Yao Z, Schank M, Zhao J, El Gazzar M, Wang L, Zhang Y
Front Genome Ed. 2024; 6:1467449.
PMID: 39444780
PMC: 11496132.
DOI: 10.3389/fgeed.2024.1467449.
Reactivation of hepatitis B virus infection - an important aspect of multifaceted problem.
Morozov S, Batskikh S
World J Gastroenterol. 2024; 30(26):3193-3197.
PMID: 39086636
PMC: 11287409.
DOI: 10.3748/wjg.v30.i26.3193.
One-Step Reverse Transcriptase qPCR Method for Serum Hepatitis B Virus RNA Quantification.
Liu S, Zhou B, Shen S, Sun J
Methods Mol Biol. 2024; 2837:159-170.
PMID: 39044083
DOI: 10.1007/978-1-0716-4027-2_14.
HBV eradication from the host: Current understanding and challenges.
Mbelle M, Dusheiko G
Clin Liver Dis (Hoboken). 2024; 23(1):e0188.
PMID: 38841198
PMC: 11152883.
DOI: 10.1097/CLD.0000000000000188.
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients.
Yuen M, Chuang W, Peng C, Jeng W, Su W, Chang T
Clin Mol Hepatol. 2024; 30(3):375-387.
PMID: 38528825
PMC: 11261219.
DOI: 10.3350/cmh.2023.0535.
Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication.
Harris J, Magri A, Faria A, Tsukuda S, Balfe P, Wing P
J Biol Chem. 2024; 300(3):105724.
PMID: 38325742
PMC: 10914488.
DOI: 10.1016/j.jbc.2024.105724.
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA.
Watanabe T, Hayashi S, Zhaoyu Y, Inada H, Nagaoka K, Tateyama M
J Gastroenterol. 2024; 59(4):315-328.
PMID: 38315437
DOI: 10.1007/s00535-023-02070-y.
Decoding the multifaceted interventions between human sirtuin 2 and dynamic hepatitis B viral proteins to confirm their roles in HBV replication.
Piracha Z, Saeed U, Piracha I, Noor S, Noor E
Front Cell Infect Microbiol. 2024; 13:1234903.
PMID: 38239506
PMC: 10794644.
DOI: 10.3389/fcimb.2023.1234903.
Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review.
Abdelwahed A, Heineman B, Wu G
J Clin Transl Hepatol. 2024; 11(7):1485-1497.
PMID: 38161502
PMC: 10752814.
DOI: 10.14218/JCTH.2023.00067.
G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes.
Giraud G, Roda M, Huchon P, Michelet M, Maadadi S, Jutzi D
Nucleic Acids Res. 2023; 52(5):2290-2305.
PMID: 38113270
PMC: 10954475.
DOI: 10.1093/nar/gkad1200.
In vitro evaluation of tropolone absorption, metabolism, and clearance.
Woodson M, Mottaleb M, Murelli R, Tavis J
Antiviral Res. 2023; 220:105762.
PMID: 37996012
PMC: 10843707.
DOI: 10.1016/j.antiviral.2023.105762.
LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.
Zhang X, Li Y, Huan C, Hou Y, Liu R, Shi H
Virol Sin. 2023; 39(1):44-55.
PMID: 37832719
PMC: 10877346.
DOI: 10.1016/j.virs.2023.10.002.
Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNA.
Hu X, Zhao L, Ou M, Chen Y, Wei H, Xia Y
Heliyon. 2023; 9(8):e18557.
PMID: 37560627
PMC: 10407120.
DOI: 10.1016/j.heliyon.2023.e18557.
IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response.
Lin M, Guo R, Zeng D, Liu J, Zheng M, Su Z
J Clin Transl Hepatol. 2023; 11(4):918-924.
PMID: 37408826
PMC: 10318274.
DOI: 10.14218/JCTH.2022.00299.
The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma.
Padarath K, Deroubaix A, Kramvis A
Viruses. 2023; 15(4).
PMID: 37112837
PMC: 10144019.
DOI: 10.3390/v15040857.